Market research
JYNT The Joint Corp
NASDAQ USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 119M
- Analyst target
- 10
- Dividend yield
- Not available
- Beta
- 1.05
Community
Investor discussion
1 comment
Sign in to join the JYNT discussion.
5 years, 4 months ago
The Joint Corp is currently in a long term uptrend where the price is trading 100.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.6.
The Joint Corp's total revenue rose by 22.8% to $17M since the same quarter in the previous year.
Its net income has increased by 723.1% to $11M since the same quarter in the previous year.
Finally, its free cash flow grew by 47.3% to $2M since the same quarter in the previous year.
Based on the above factors, The Joint Corp gets an overall score of 5/5.